Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that VS-6063 has received orphan medicinal product designation from the European Commission for use in mesothelioma.
http://www.businesswire.com/news/topix/20130613005354/en
http://www.businesswire.com/news/topix/20130613005354/en
No comments:
Post a Comment